Updates on postpartum hemorrhage: prediction, early detection and management
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20242849Keywords:
Postpartum haemorrhage, Early detection, Updates, Prevention, E-motiveAbstract
Postpartum hemorrhage (PPH) continues to pose a significant threat to maternal health worldwide, despite advancements in obstetric care. This article provides an overview of recent updates in the management of PPH, focusing on strategies aimed at enhancing outcomes and minimizing complications. Current guidelines underscore the importance of early identification and immediate intervention in the management of PPH. Machine learning models (MLMs), E-motive approach, estimation of serum fibrinogen levels and ABL estimation Active management protocols advocate for the administration of carbetocin and use of negative intrauterine pressure suction device in high-risk cases to mitigate blood loss. In cases where initial pharmacological interventions fail to control bleeding, alternative measures such as balloon tamponade or uterine artery embolization (UAE) may be necessary. Innovations like the Bakri balloon, NASG, UAE have revolutionized the management of atonic PPH by offering a non-surgical option for hemorrhage control. Permissive resuscitation, recombinant active factor seven (VIIa), desmopressin acetate (DDAVP) and lyophilized fibrinogen concentrate have proven to be beneficial in refractory PPH. Efforts are ongoing to develop less invasive techniques that prioritize maternal fertility and minimize morbidity. Furthermore, the integration of multidisciplinary teams and simulation training plays a pivotal role in enhancing PPH management.
References
Weeks A. The prevention and treatment of postpartum hemorrhage: what do we know, and where do we go to next? BJOG. 2015;122:202-10.
Widmer M, Piaggio G, Hofmeyr GJ, Carroli G, Coomarasamy A, Galloset I, et al. Maternal characteristics and causes associated with refractory postpartum hemorrhage after vaginal birth: a secondary analysis of the WHO champion trial data. BJOG. 2020;127:628-34.
Venkatesh KK, Strauss RA, Grotegut CA, Heine RP, Chescheir NC, Stringer JSA, et al. Machine Learning and Statistical Models to Predict Postpartum Hemorrhage. Obstetrics C Gynecol. 2020;135(4):935-44.
Akazawa M, Hashimoto K, Katsuhiko N, Kaname Y. Machine learning approach for the prediction of postpartum hemorrhage in vaginal birth. Scientific Rep. 2021;11(1):22620.
Shah SY, Saxena S, Rani SP, Nelaturi N, Gill S, Tippett Barr B, et al. Prediction of postpartum hemorrhage (PPH) using machine learning algorithms in a Kenyan population. Frontiers in Global Women's Health. 2023;4:1161157.
Gallos I, Devall A, Martin J, Middleton L, Beeson L, Galadanci H, et al. Randomized trial of early detection and treatment of postpartum hemorrhage. N Eng J Med. 2023;389(1):11-21.
Forbes G, Akter S, Miller S, Galadanci H, Ǫureshi Z, Fawcus S, et al. Factors influencing postpartum hemorrhage detection and management and the implementation of a new postpartum hemorrhage care bundle (E-MOTIVE) in Kenya, Nigeria, and South Africa. Implementation Sci. 2023;18(1):1.
Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe hemodilution: an in vitro model. Br J Anaesth. 2009;102:793-9.
Agarwal R, Jaiswal N, Kar R, Singh A, Srivastava H. Is serum fibrinogen an affirmative marker for vaginal delivery without PPH? Ind J Obstet Gynaecol. 2020;6(2):113-8.
Zakaria AE, Sedek AE, Aly MA, Mohamed MA. Serum Fibrinogen as A detection of Severity of Postpartum Hemorrhage. Egypt J Hosp Med. 2019;76(5):4189-94.
Powell E, James D, Collis R, Collins PW, Pallmann P, Bell S. Introduction of standardized, cumulative quantitative measurement of blood loss into routine maternity care. J Maternal-Fetal C Neonatal Med. 2022;35(8):1491-7.
Athar MW, Abir G, Seay RC, Guo N, Butwick A, Carvalho B. Accuracy of visual estimation of blood loss in obstetrics using clinical reconstructions: an observational simulation cohort study. Int J Obstetr Anesthesia. 2022;50:103539.
Nair AS, Naik V, Busa N, Rayani BK. Triton sponge and canister app for estimating surgical blood loss. Saudi J Anaesth. 2019;13:390-1.
Gerdessen L, Meybohm P, Choorapoikayil S, Herrmann E, Taeuber I, Neef V, et al. Comparison of common perioperative blood loss estimation techniques: a systematic review and meta-analysis. J Clin Monitoring Computing. 2021;35(2):245-58.
Kumar S, Yadav V, Balasubramaniam S, Jain Y, Joshi CS, Saran K, et al. Effectiveness of the WHO SCC on improving adherence to essential practices during childbirth, in resource constrained settings. BMC Pregnancy Childbirth. 2016;16(1):345.
Bruce KE, Desai S, Reilly K, Keil A, Swanson M, Cobb B, et al. Use of Postpartum Hemorrhage Checklist during Vaginal Deliveries: A Ǫuality Improvement Study. Am J Perinatol. 2024;NA.
Nathan HL, Ayadi AE, Hezelgrave NL, Seed P, Butrick E, Miller S, et al. Shock index: an effective predictor of outcome in postpartum hemorrhage? JOG Int J Obstet Gynaecol. 2015;122(2):268-75.
Kohn JR, Dildy GA, Eppes CS. Shock index and delta-shock index are superior to existing maternal early warning criteria to identify postpartum hemorrhage and need for intervention. J Matern Fetal Neonatal Med 2019;32(8):1238-44.
El Ayadi AM, Nathan HL, Seed PT, Butrick EA, Hezelgrave NL, Shennan AH, et al. Vital sign prediction of adverse maternal outcomes in women with hypovolemic shock: the role of shock index. PLoS One. 2016;11(2):e0148729.
Parameshwar PS, Bianco K, Sherwin EB, Meza PK, Tolani A, Bates P, et al. Mixed methods evaluation of simulation-based training for postpartum hemorrhage management in Guatemala. BMC Pregnancy Childbirth. 2022;22:513.
The Joint Commission. Preventing infant death and injury during delivery. Sentinel Event ALERT No. 30. 2009.
WHO recommendations: Uterotonics for the prevention of postpartum hemorrhage. Geneva: world health Organization. Recommendations and supporting evidence. 2018;3. Available at: https://iris.who.int/bitstream/handle/10665/277276/9789241550420-eng.pdf. Accessed on 17 March 2024.
Widmer M, Piaggio G, Nguyen TMH, Osoti A, Owa OO, Misra S, et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med. 2018;379(8):743-52.
Elbohoty AEH, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. Int J Gynaecol Obstet. 2016;134(3):324-8.
Jin V, Du Y, Zhang F, Zhang K, wang l, Cui l. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2016;29(3):400-7.
Center for Devices, and Radiological Health. Device approvals, denials and clearances. U.S. Food and Drug Administration. 2022.
Goffman D, Rood KM, Bianco M, Biggio JR, Dietz P, Drake K, et al. Real-World Utilization of an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device Obstet Gynecol. 2023;142(5):1006-16.
Cebekhulu SN, Abdul H, Batting J, Chauke L, Dlakavu F, Fawcus S, et al. Suction Tube Uterine Tamponade” for treatment of refractory postpartum hemorrhage: Internal feasibility and acceptability pilot of a randomized clinical trial. Int J Gynecol C Obstetr. 2022;158(1):79-85.
Pandey A, Kumari N. Intrauterine suction for control of atonic PPH. Indian J Scient Res. 2021;12(1):103-6.
Theron GB. Management of postpartum hemorrhage with free-flow pressure controlled uterine balloon. Int J Gynecol Obstet. 2018;142:371-3.
Burke TF, Danso-Bamfo S, Guha M, Oguttu M, Tarimo V, Nelson BD. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynecol Obstet. 2017;139:34-8.
Suarez S, Conde-Agudelo A, Borovac-Pinheiro A, Suarez-Rebling D, Eckardt M, Theron G, et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;222:293.
Gauchotte E, De La Torre M, Perdriolle-Galet E, Lamy C, Gauchotte G, Morel O. Impact of uterine balloon tamponade on the use of invasive procedures in severe postpartum hemorrhage. Acta Obstet Gynecol Scand. 2017;96(7):877-82.
Gizzo S, Saccardi C, Patrelli TS, Gangi SD, Breda E, Fagherazzi S, et al. Fertility rate and subsequent pregnancy outcomes after conservative surgical techniques in postpartum hemorrhage: 15 years of literature. Fertil Steril. 2013;99(7):2097-107.
Giacalone S, Kottmann A, Darioli V, Carron PN, Desseauve D, Albrecht R, et al. Clinical characteristics and hemodynamic state of patients undergoing interhospital transfer for postpartum hemorrhage: A study of a single-center helicopter emergency medical service. Eur J Obstetr Gynecol Reproduct Biol. 2022;268:48-55.
Hiebert B, Nouvet E, Jeyabalan V, Donelle L. The Application of Drones in Healthcare and Health- Related Services in North America: A Scoping Review. Drones 2020;4:30.
Braun J, Gertz SD, Furer A, Bader T, Frenkel H, Chen J, et al. The promising future of drones in prehospital medical care and its application to battlefield medicine. J Trauma Acute Care Surg. 2019;87(1S):S28-34.
FIGO Safe Motherhood and Newborn Health Committee, International Federation of Gynecology and Obstetrics. Non-pneumatic anti-shock garment to stabilize women with hypovolemic shock secondary to obstetric hemorrhage. Int J Gynecol Obstet. 2015;128:194-5.
Althabe F, Therrien MNS, Pingray V, Hermida J, Gülmezoglu AM, Armbruster D, et al. Postpartum hemorrhage care bundles to improve adherence to guidelines: a WHO technical consultation. Int J Gynecol Obstet. 2020;148:290-9.
Mourad-Youssif M, Ojengbede OA, Meyer CD, Fathalla M, Morhason-Bello IO, Galadanci H, et al. Can the Non-pneumatic Anti-Shock Garment (NASG) reduce adverse maternal outcomes from postpartum hemorrhage? Evidence from Egypt and Nigeria. Reprod Health. 2010;7:24.
Ramalingappa P, Shruthi HS, Raksha S. Impact of non-pneumatic anti shock garment in reducing postpartum hemorrhage-a tertiary centre experience. N Indian J OBGYN. 2022;9(1):117-21.
World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. Available at: https://www.who.int/publications/i/item/9789241565493. Accessed on 17 March 2024.
NA. Prevention and management of postpartum hemorrhage: green-top guideline no. 52. BJOG. 2017;124:e106-49.
Schlimp CJ, Ponschab M, Voelckel W, Treichl B, Maegele M, Schochl H, et al. Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: A retrospective study. Scand J Trauma Resusc Emerg Med. 2016;24(1):29.
Ducloy-Bouthors AS, Mercier FJ, Grouin JM, Bayoumeu F, Corouge J, Gouez AL, et al. Early and systematic administration of fibrinogen concentrate in postpartum hemorrhage following vaginal delivery: the FIDEL randomized controlled trial. BJOG. 2021;128:1814-23.
Kikuchi M, Itakura A, Miki A, Nishibayashi M, Ikebuchi K, Ishihara O, et al. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res. 2013;39:770-6.
Magon N, Babu K. Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium. N Am J Med Sci. 2012;4(4):157-62.
Barillari G, Frigo MG, Casarotto M, Farnia A, Massè B, Wetzl R, et al. Use of recombinant activated factor VII in severe post-partum hemorrhage: Data from the Italian Registry. Thromb Res. 2009;124:e41-7.
Surbek D, Blatný J, Wielgos M, Acs N, Edwards H, Erez O, et al. Role of recombinant factor VIIa in the clinical management of severe postpartum hemorrhage: consensus among European experts. J Matern Fetal Neonatal Med. 2024;37(1):2332794.
Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum hemorrhage (WOMAN): an international, randomized, double-blind, placebo-controlled trial. Lancet. 2017;389:2105-16.
Mohinani A, Patel S, Tan V, Kartika T, Olson S, DeLoughery TG, et al. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders. Eur J Haematol. 2023;110(5):470-9.
Ozgonenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J. 2007;83(977):159-63.
McCarty TS, Shah AD. Desmopressin. Stat Pearls. 2021.
Carvajal JA, Ramos I, Kusanovic JP, Escobar MF. Damage control resuscitation in obstetrics. J Matern Fetal Neonatal Med. 2022;35:785-98.
Gillissen A, van den Akker T, Caram-Deelder C, C A Henriquez DD, Bloemenkamp KWM, et al. Association between fluid management and dilutional coagulopathy in severe postpartum hemorrhage: a nationwide retrospective cohort study. BMC Pregnancy Childbirth. 2018;18:398.
Nagy CJ, Wheeler AS, Archer TL. Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah’s Witness with placenta percreta. Int J Obstet Anesth. 2008;17:159-63.
